Darnaud, M., Dos Santos, A., Gonzalez, P., Augui, S., Lacoste, C., Desterke, C., De Hertogh, G., Valentino, E., Braun, E., Zheng, J., Brechot, C., et al. (2018). Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. Gastroenterology 154, 1009-1023.e14

Nalpas, B., Ichaï, P., Jamot, L., Carbonell, N., Rudler, M., Mathurin, P., Durand, F., Gerken, G., Manns, M., Trautwein, C., Amouyal, G., Amouyal, P., Bréchot, C., et al. (2016). A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases. PLoS ONE 11, e0150733

Moniaux, N., Darnaud, M., Garbin, K., Dos Santos, A., Guettier, C., Samuel, D., Amouyal, G., Amouyal, P., Bréchot, C., and Faivre, J. (2015). The Reg3α (HIP/PAP) Lectin Suppresses Extracellular Oxidative Stress in a Murine Model of Acute Liver Failure. PLoS ONE 10, e0125584.

Haldipur, P., Dupuis, N., Degos, V., Moniaux, N., Chhor, V., Rasika, S., Schwendimann, L., le Charpentier, T., Rougier, E., Amouyal, P., Amouyal, G., Bréchot, C., et al. (2014). HIP/PAP prevents excitotoxic neuronal death and promotes plasticity. Ann Clin Transl Neurol 1, 739–754.

Vibert, E., Pittau, G., Gelli, M., Cunha, A.S., Jamot, L., Faivre, J., Castro Benitez, C., Castaing, D., and Adam, R. (2014). Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases. Surgery 155, 94–105.

Moniaux, N., Darnaud, M., Dos Santos, A., Jamot, L., Samuel, D., Amouyal, P., Amouyal, G., Bréchot, C., and Faivre, J. (2012). HIP/PAP, un nouveau médicament contre les hépatites aiguës graves. Med Sci (Paris) 28, 239–241.

Nalpas, B., Francoz, C., Ichaï, P., Jamot, L., Faivre, J., Lemoinne, S., Samuel, D., Durand, F., Bernuau, J., Bréchot, C., Amouyal, G., Amouyal, P., (2012). Prothrombin index slope is an early prognostic marker in patients with severe acute liver diseases. Gut 61, 1098–1100.

Moniaux, N., Song, H., Darnaud, M., Garbin, K., Gigou, M., Mitchell, C., Samuel, D., Jamot, L., Amouyal, P., Amouyal, G., Bréchot, C., et al. (2011). Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers. Hepatology 53, 618–627.